Skip to main content
Log in

Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administration

  • Clinical Studies
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

The effect of administering increasing intravenous doses of difluoromethylornithine on human tumor cell polyamine levels was determined in patients with hematologic malignancies. Difluoromethylornithine from 5.5. to 64 gm/m2 per day was administered to nine patients with refractory acute leukemia or multiple myeloma. Putrescine, spermidine, and spermine levels were determined on a daily basis in the circulating mononuclear cells and on a weekly basis in the mononuclear cells of the bone marrow. Tumor cell putrescine levels declined in 5 patients, spermidine levels declined in 4 patients, and spermine levels declined in 3 patients. Alterations in the polyamine levels of the bone marrow mononuclear cells paralleled those occuring in the peripheral blood mononuclear cells in the patients with leukemia. Seven to ten days of DFMO treatment were required for mononuclear cell polyamine levels to decrease. The higher drug doses were not significantly more effective than the lower doses in bringing about a decline in tumor cell polyamine levels, either with respect to treatment time required for onset of response or with respect to the ultimate extent of response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

DFMO:

Difluoromethylornithine

ODC:

ornithine decarboxylase

AML:

Acute Myeloge-nous Leukemia

MM:

Multiple Myeloma

WBC:

Mononuclear White Blood Cell

MGBG:

methylglyoxal bis(guanylhydrazone)

References

  1. Metcalf BW, Bey P, Danzin C, Jung MJ, Casara P, Vevert JP: Catalytic irreversible inhibition of mammalian ornithine decarboxylase by substrate and product analogues. J Am Chem Soc 100:2551–2553, 1978

    Google Scholar 

  2. Sjoerdsma A: Suicide enzyme inhibitors as potential drugs. Clin Pharmacol Ther 30:3–22, 1981

    Google Scholar 

  3. Pegg AE, McCann PP: Polyamine metabolism and function. Am J Physiol 243 (Cell Physiol 12):C212-C22l, 1982

    Google Scholar 

  4. Tabor CW, Tabor H: Polyamines. Ann Rev Biochem 53:749–790, 1984

    Google Scholar 

  5. Janne J, Poso H, Raina A: Polyamines in rapid growth and cancer. Biochem Biophys Acta 473:241–293, 1978

    Google Scholar 

  6. Durie BGM, Salmon SE, Russell DH: Polyamines as markers of response and disease activity in cancer chemotherapy. Cancer Res 37;214–221, 1977

    Google Scholar 

  7. Horn T, Beal SL, Walach N, Lubich WP, Spigel L, Marton LJ: Further evidence for the use of polyamines as biochemical markers for malignant tumors. Cancer Res 42:3248–3251, 1982

    Google Scholar 

  8. Russell DH: Clinical relevance of polyamines. CRC Critical Rev Clin Laboral Sci 18:261–311, 1982

    Google Scholar 

  9. Mamont PS, Duchesne MC, Grove J, Bey P: Antiproliferative properties of DL-alpha-difluoromethylornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase. Biochem Biophys Res Commun 81:58–66, 1978

    Google Scholar 

  10. Danzin C, Jung MJ, Grove J, Bey P: Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on polyamine levels in rat tissues. Life Sci 24:519–524, 1979

    Google Scholar 

  11. Fozard JR, Part ML, Prakash NJ, Grove J, Schechter PJ, Sjoerdsma A, Koch-Weser J: L-Ornithine decarboxylase: An essential role in early mammalian embryogenesis. Science 208;505–508, 1980

    Google Scholar 

  12. Luk GD, Marton LJ, Baylin SB: Ornithine decarboxylase is important in intestinal mucosal maturation and recovery from injury in rats. Science 210:195–198, 1980

    Google Scholar 

  13. Luk GD, Sharkis SJ, Abeloff MD, McCann PO, Sjoerdsma A, Baylin SB: Polyamine biosynthesis is required for the maintenance of peripheral blood cell elements in the rat. Proc Natl Acad Sci USA 80:5090–5093, 1983

    Google Scholar 

  14. Luk GD, Goodwin G, Marton LJ, Baylin SB: Polyamines are necessary for the survival of human small-cell carcinoma in culture. Proc Natl Acad Sci USA 78:2355–2358, 1981

    Google Scholar 

  15. Prakash NJ, Schechter PJ, Grove J, Koch-Weser J: Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice. Cancer Res 38:3059–3062, 1978

    Google Scholar 

  16. Cavanaugh PF Jr, Pavelic ZP, Porter CW: Enhancement of l,3-bis(2-chloroethyl)-l-nitrosourea-induced cytotoxicity and DNA damage by alpha-difluoromethylornithine in L1210 leukemia cells. Cancer Res 44:3856–3861, 1984

    Google Scholar 

  17. Manon LJ, Levin VA, Hervatin SJ, Koch-Weser J, McCann PP, Sjoerdsma A: Potentiation of the therapeutic effects of l,3,-bis(2-chloroethyl)-l-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor. Cancer Res 41:4426–4431, 1981

    Google Scholar 

  18. Seppanen P, Alhonen-Hongisto L, Janne J: Death of tumor cells in response to the use of a system of stimulated polyamine uptake for the transport of methylglyoxal bis(guanylhydrazone). Eur J Biochem 118:571–576, 1981

    Google Scholar 

  19. Seppanen P, Alhonen-Hongisto L, Janne J: Polyamine deprivation-induced enhanced uptake of methylglyoxal bis(guanylhydrazone) by tumor cells. Biochim Biophys Acta 674:169–177, 1981

    Google Scholar 

  20. Bacchi CJ, Nathan HC, Hutner SH, McCann PP, Sjoerdsma A: Novel combination chemotherapy of experimental trypanosomiasis by using bleomycin and DL-α-difluoromethylornithine; reversal by polyamines. Biochem Pharmacol 31:2833–2836, 1982

    Google Scholar 

  21. Bacchi CJ, Nathan HC, Hutner SH, McCann PP, Sjoerdsma A: Polyamine metabolism: a potential therapeutic target in trypanosomes Science 210:332–334, 1980

    Google Scholar 

  22. Abeloff MD, Slavik M, Luk GD, Griffin CA, Hermann J, Blac O, Sjoerdsma A, Baylin SB: Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine — an inhibitor of polyamine biosynthesis. J Clin Oncol 2:124–130, 1984

    Google Scholar 

  23. Maddox AM, Freireich EJ, Keating MJ, Haddox MK: Pharmacology of the polyamine inhibitor alpha-difluoromethylornithine (DFMO) in patients with hematologic malignancies. (Abstract) Proc Am Assoc Canc Res C162:42, 1984

    Google Scholar 

  24. Maddox AM, Keating MJ, McCredie KE, Estey E, Freireich EJ: Phase I evaluation of intravenous difluoromethylornithine — a polyamine inhibitor. Invest New Drugs 3:59–64, 1985

    Google Scholar 

  25. Siimes M, Seppanen P, Alhonen-Hongisto L, Janne J: Synergistic action of two polyamine antimetabolites leads to rapid therapeutic response in childhood leukemia. Int J Cancer 28:567–570, 1981

    Google Scholar 

  26. Warrell RP, Coonley CJ, Burchenal JH: Sequential inhibition of polyamine synthesis. A phase I trial of DFMO (alpha-difluoromethylornithine) and methyl-GAG [methylglyoxal-bix(guanylhydrazone)]. Cancer Chemother Pharmacol 11:134–136, 1983

    Google Scholar 

  27. Golden JA, Sjoerdsma A, Santi DV: Pneumocystis carinii pneumonia treated with alpha-difluoromethylornithine. Western Jour Med 141:613–623, 1984

    Google Scholar 

  28. Sjoerdsma A, Golden JA, Schechter PJ, Barlow JLR, Santi DV: Successful treatment of lethal protozoal infections with the ornithine decarboxylase inhibitor, alpha-difluoromethylornithine. Trans Assoc Am Phys XCVII:70–79, 1984

    Google Scholar 

  29. Sjoerdsma A, Schechter PJ: Chemotherapeutic implications of polyamine biosynthesis inhibition. Clin Pharm Therap 35:287–300, 1984

    Google Scholar 

  30. Van Nieuwenhove S, Schechter PJ, Declercq J, Bone G, Burke J, Sjoerdsma A: Treatment of Gambiense sleeping sickness in the Sudan with oral DFMO (D-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial. Trans Royal Soc Trop Med Hyg 79:692–698, 1985

    Google Scholar 

  31. Booyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 21:77–80, 1968

    Google Scholar 

  32. Sunkara PS, Fowler SK, Nishioka K, Rao PN: Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine potentiates the cytotoxic effects of arabinosyl cytosine in HELA cells. Biochem Biophys Res Commun 95:423–430, 1980

    Google Scholar 

  33. Sunkara PS, Prakash NJ, Mayer GD, Sjoerdsma A: Tumor suppression with a combination of alpha-difluoromethylornithine and interferon. Science 219:851–853, 1983

    Google Scholar 

  34. Miale TD, Rennert OM, Lawson DL, Shukla JB, Frias JL: Bone marrow polyamines in children with acute leukemia as related to remission status, therapy, and cellularity of specimens. Med Pediat Oncol 3:209–230, 1977

    Google Scholar 

  35. Kapyaho K, Linnamaa K, Janne J: Effect of epidermal polyamine depletion on the accumulation of methylglyoxal bis(guanylhydrazone) in mouse skin. J Invest Dermal 82:391–394, 1982

    Google Scholar 

  36. Kallio A, Seppanen P, Alhonen-Hongisto L, Janne J: Modulation of the tissue disposition of methylglyoxal bis (guanylhydrazone) in mice by polyamine depletion and by polyamine administration. Cancer Res 43:324–327, 1983

    Google Scholar 

  37. Prakash NJ, Sunkara PS: Combination chemotherapy involving alpha-difluoromethylornithine and 1-β-D-arabinofuranosylcytosine in murine L1210 leukemia. Cancer Res 43:3192–3196, 1983

    Google Scholar 

  38. Kingsnorth AN, McCann PP, Diekema KA, Ross JS, Malt RA: Effects of alpha-difluoromethylornithine on the growth of experimental Wilms tumor and renal adenocarcinoma. Cancer Res 43:4031–4034, 1983

    Google Scholar 

  39. Kingsnorth AN, King WWK, Diekema KA, McCann PP, Ross JS, Malt RA: Inhibition of ornithine decarboxylase with α-difluoromethylornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice. Cancer Res 43:2545–2549, 1983

    Google Scholar 

  40. Fozard JR, Prakash NJ: Effects of DL-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, on the rat mammary tumour induced by 7,12-Dimethylbenz [ ] anthracene. Naunyn-Schmiedeberg's Arch Pharmacol 320:72–77, 1982

    Google Scholar 

  41. Weeks CE, Herrmann AL, Nelson FR, Slaga TJ: Alphadifluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. Proc Natl Acad Sci USA 79:6028–6032, 1982

    Google Scholar 

  42. Alhonen-Hongisto L, Seppanen P, Janne J: Intracellular putrescine and spermidine deprivation induces increased uptake of the natural polyamines and methylglyoxal bis(guanylhydrazone). Biochem J 192:941–945, 1980

    Google Scholar 

  43. Kallio A, Nikula P, Janne J: Transfer of intestine-derived diamines into tumor cells during treatment of Ehrlichascites-carcinoma-bearing mice with polyamine anti-metabolites. Biochem J 218:641–644, 1984

    Google Scholar 

  44. Kufe DW, Griffin J, Mitchell T, Shafman T: Polyamine requirements for induction of HL-60 promyelocyte differentiation by leukocyte-conditioned medium and phorbol ester. Cancer Res 44:4281–4284, 1984

    Google Scholar 

  45. Sugiura M, Shaftman T, Mitchell T, Griffin J, Kufe D: Involvement of spermidine in proliferation and differentiation of human promyelocytic leukemia cells. Blood 63:1153–1158, 1984

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Recipient of NIH Posdoctoral Fellowship NRSA AMO7331.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maddox, AM., Freireich, E.J., Keating, M.J. et al. Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administration. Invest New Drugs 6, 125–134 (1988). https://doi.org/10.1007/BF00195371

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00195371

Key words

Navigation